Literature DB >> 7814864

Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines.

J H Cox1, P Galardy, J R Bennink, J W Yewdell.   

Abstract

Little is known regarding the mechanism by which MHC class I-associated peptides are generated. Proteins can be targeted for degradation by the covalent attachment of ubiquitin. The first step in ubiquitin conjugation to proteins is its binding to E1 ubiquitin-activating enzyme. To study the role of ubiquitin-targeted protein degradation in Ag processing, we used two mutant cell lines with temperature-sensitive E1 proteins, and a recombinant vaccinia virus expressing wild-type human E1. One of the cell lines examined (hamster ts20 cells) was previously reported to have a minimal capacity after a 1-h incubation at 41 degrees C to present osmotically loaded OVA to a T cell hybridoma, as assessed by IL-2 release. Even after incubating the same cells for 1 h at 43 degrees C, we failed to detect an E1-related decrease in the presentation of biosynthesized or osmotically loaded OVA to splenic T cells, as measured by target cell lysis. We introduce the use of mouse tsA1S9 cells to Ag-processing studies and provide the initial biochemical characterization of their defect in protein ubiquitination. Relative to parental L929 cells, after thermal inactivation of E1, these cells actually demonstrate enhanced presentation of endogenous or exogenous viral Ags to T cells. Our findings do not support a role for protein ubiquitination in Ag processing, and indicate that either the temperature-sensitive cell lines examined do not exhibit a sufficient reduction in ubiquitin-conjugating activity to affect the generation of antigenic peptides, or that ubiquitin-targeted proteolysis is not essential for processing the two exogenous and six endogenous Ags examined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814864

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction.

Authors:  F Rodriguez; J Zhang; J L Whitton
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation.

Authors:  Lan Huang; Julie M Marvin; Nia Tatsis; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

4.  Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.

Authors:  Jiajie Wei; Damien Zanker; Anthony R Di Carluccio; Margery G Smelkinson; Kazuyo Takeda; Mina O Seedhom; Devin Dersh; James S Gibbs; Ning Yang; Ajit Jadhav; Weisan Chen; Jonathan W Yewdell
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 5.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Authors:  Brian P Dolan; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Mol Life Sci       Date:  2011-03-17       Impact factor: 9.261

6.  Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.

Authors:  A Castilleja; N E Ward; C A O'Brian; B Swearingen; E Swan; M A Gillogly; J L Murray; A P Kudelka; D M Gershenson; C G Ioannides
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

7.  CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.

Authors:  U Schubert; L C Antón; I Bacík; J H Cox; S Bour; J R Bennink; M Orlowski; K Strebel; J W Yewdell
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Retroviruses have differing requirements for proteasome function in the budding process.

Authors:  David E Ott; Lori V Coren; Raymond C Sowder; Julian Adams; Ulrich Schubert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

9.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Authors:  K B Hendil; S Khan; K Tanaka
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 10.  Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.

Authors:  Luis C Antón; Jonathan W Yewdell
Journal:  J Leukoc Biol       Date:  2014-02-14       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.